Therapeutic and toxicological evaluations of cyclosporine A microspheres as a treatment vehicle for uveitis in rabbits

Journal of Ocular Pharmacology and Therapeutics

Volumn 22, Issue 2, 2006, Pages 121-131

  He, Yuan ^a   Wang, Jian Cheng ^b   Liu, Yu Ling ^a   Ma, Zhi Zhong ^a   Zhu, Xiu An ^a   Zhang, Qiang ^b  

^a PEKING UNIVERSITY THIRD HOSPITAL   (China)

^b PEKING UNIVERSITY HEALTH SCIENCE CENTER   (China)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOSPORIN; DRUG VEHICLE; LIPOPOLYSACCHARIDE; MACROGOL 10000; MICROSPHERE; POLOXAMER; POLYGLACTIN; SOLVENT;

ANALYTICAL PARAMETERS; ANIMAL CELL; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; B WAVE; CELL INFILTRATION; CONTROLLED STUDY; DRUG DELIVERY SYSTEM; DRUG EFFICACY; DRUG FORMULATION; DRUG RELEASE; ELECTRORETINOGRAPHY; ENTRAPMENT EFFICIENCY; EVAPORATION; EXPERIMENTAL MODEL; EYE TOXICITY; HISTOLOGY; IN VITRO STUDY; IN VIVO STUDY; INFLAMMATION; LEUKOCYTE COUNT; MORPHOLOGY; NONHUMAN; OPHTHALMOSCOPY; PARTICLE SIZE; PROTEIN DETERMINATION; RABBIT; SLIT LAMP; UVEITIS;

ANIMALS; AQUEOUS HUMOR; BIOCOMPATIBLE MATERIALS; CYCLOSPORINE; DISEASE MODELS, ANIMAL; DRUG CARRIERS; ELECTRORETINOGRAPHY; EYE; IMMUNOSUPPRESSIVE AGENTS; INJECTIONS; LACTIC ACID; LEUKOCYTE COUNT; LEUKOCYTES; MICROSPHERES; PARTICLE SIZE; POLYGLYCOLIC ACID; POLYMERS; RABBITS; SOLUBILITY; UVEITIS;

EID: 33646684466     PISSN: 10807683     EISSN: None     Source Type: Journal    
DOI: 10.1089/jop.2006.22.121     Document Type: Article

References (21)

1. Koga, T., Koshiyama, Y., Gotoh, T., et al. Coinduction of nitric oxide synthase and arginine metabolic enzymes in endotoxin-induced uveitis rats. Exp. Eye Res. 75:659-667, 2002.
2. Hanashiro, R.K., Fujino, Y., Gugunfu, et al. Synthetic lipid A-induced uveitis and endotoxin-induced uveitis-a comparative study. Jpn. J. Ophthalmol. 41:355-361, 1997.
3. Rosenbaum, J.T., McDevitt, H.O., Guss, R.B., et al. Endotoxin-induced uveitis in rats as a model for human disease. Nature 286:611-613, 1980.
4. BenEzra, D. and Maftzir, G. Ocular penetration of cyclosporine A in the rat eye. Arch. Ophthalmol. 108:584-587, 1990.
5. Nussenblatt, R.B., Dinning, W.J., Fujikawa, L.S., et al. Local cyclosporine therapy for experimental autoimmune uveitis in rats. Arch. Ophthalmol. 103:1559-1562, 1985.
6. Grisolano, J., Jr. and Peyman, G.A. Retinal toxicity study of intravitreal cyclosporin. Ophthal. Surg. 17:155-156, 1986.
7. Alghadyan, A.A., Peyman, G.A., Khoobehi, B., et al. Liposome-bound cyclosporine: Clearance after intravitreal injection. Int. Ophthalmol. 12:109-112, 1988.
8. Pearson, P.A., Jaffe, G.J., Martin, D.F., et al. Evaluation of a delivery system providing long-term release of cyclosporine. Arch. Ophthalmol. 114:311-317, 1996.
9. Jaffe, G.J., Yang, C.S., Wang, X.C., et al. Intravitreal sustained-release cyclosporine in the treatment of experimental uveitis. Ophthalmology 105:46-56, 1998.
10. Gilger, B.C., Wilkie, D.A., Davidson, M.G., et al. Use of an intravitreal sustained-release cyclosporine delivery device for treatment of equine recurrent uveitis. Am. J. Vet. Res. 62:1892-1896, 2001.
11. Gilger, B.C., Malok, E., Stewart, T., et al. Effect of an intravitreal cyclosporine implant on experimental uveitis in horses. Vet. Immunol. Immunopathol. 76:239-255, 2000.
12. Theng, J.T., Ti, S.E., Zhou, L., et al. Pharmacokinetic and toxicity study of an intraocular cyclosporine DDS in the anterior segment of rabbit eyes. Invest. Ophthalmol. Vis. Sci. 44:4895-4899, 2003.
13. Enyedi, L.B., Pearson, P.A., Ashton, P., et al. An intravitreal device providing sustained release of cyclosporine and dexamethasone. Curr. Eye Res. 15:549-557, 1996.
14. Harper, C.A., III, Khoobehi, B., Peyman, G.A., et al. Bioavailability of microsphere-entrapped cyclosporine A in the cornea and aqueous of rabbits. Int. Ophthalmol. 17:337-340, 1993.
15. Rojas-Silva, M.V., Rodriguez-Ares, M.T., Sanchez-Salorio, M., et al. Efficacy of subconjunctival cyclosporin-containing microspheres on keratoplasty rejection in the rabbit. Graefes' Arch. Clin. Exp. Ophthalmol. 237:840-847, 1999.
16. Vallelado, A.I., Lopez, M.I., Calonge, M., et al. Efficacy and safety of microspheres of cyclosporin A, a new systemic formulation, to prevent corneal graft rejection in rats. Curr. Eye Res. 24:39-45, 2002.
17. Sawchuk, R.J. and Cartier, L.L. Liquid-chromatographic determination of cyclosporin A in blood and plasma. Clin. Chem. 27:1368-1371, 1981.
18. Hoekzema, R., Murray, P.I., van Haren, M.A., et al. Analysis of interleukin-6 in endotoxin-induced uveitis. Invest. Ophthalmol. Vis. Sci. 32:88-95, 1991.
19. Cheng, C.K., Berger, A.S., Pearson, P.A., et al. Intravitreal sustained-release dexamethasone device in the treatment of experimental uveitis. Invest. Ophthalmol. Vis. Sci. 36:442-453, 1995.
20. Jaffe, G.J., Yang, C.H., Guo, H., et al. Safety and pharmacokinetics of an intraocular fluocinolone acetonide sustained delivery device. Invest. Ophthalmol. Vis. Sci. 41:3569-3575, 2000.
21. Lai, C.C., Gouras, P., Doi, K., et al. Local immunosuppression prolongs survival of RPE xenografts labeled by retroviral gene transfer. Invest. Ophthalmol. Vis. Sci. 41:3134-3141, 2000.